Skip to cookie consent Skip to main content

Yi Liu, PhD

Manager, Business Development and Licensing

Yi Liu, PhD, is a business development and licensing manager at Mass General Brigham Innovation, where she supports commercialization efforts of technologies arising from the cardiology departments at both Massachusetts General Hospital and Brigham and Women’s Hospital.

 

Before joining Mass General Brigham, Yi was a business development manager at Rarestone, a venture-backed rare disease company focused on building the first rare disease ecosystem in China through in-licensing, and a senior analyst at Health Advance, a health care strategy consulting firm. Yi earned a PhD in molecular genetics and infectious diseases from the University of Texas Health Science Center at Houston. 

Affiliations